• Nicotine Signaling and Chronic Kidney Disease

  2026-10-12

  Jain and Jaimes present a narrative review of clinical and experimental evidence linking cigarette smoking—and potentially nicotine itself—to chronic kidney disease progression. The evidence supports biologic plausibility through nicotinic acetylcholine receptors, oxidative stress, hemodynamic effects and pro-fibrotic signaling, but does not establish nicotine as the sole causal component of tobacco-related renal injury or connect these findings to SAR131675.

• Latrunculin B and GCRV Entry: What the Study Shows

  2026-10-12

  Wang et al. used pharmacological inhibitor profiling, microscopy, and quantitative molecular measurements to examine how two grass carp reovirus strains enter cultured fish cells. Their reported data support a clathrin-associated, dynamin-dependent and pH-sensitive entry model for GCRV104, while latrunculin B did not significantly inhibit infection under the tested study conditions. That negative result is informative but limited: it does not establish that actin is irrelevant to every stage of infection, virus strain, or cell type.

• SAF312 and TRPV1 in Ocular Surface Pain

  2026-10-10

  Mogi et al. evaluated SAF312, a selective TRPV1 antagonist, across human ocular tissue, cellular pharmacology, pharmacokinetic, safety, and corneal-healing models. The study supports a preclinical rationale for locally targeting TRPV1 in ocular surface pain, while its findings remain limited to mechanistic and animal evidence rather than clinical efficacy.

• From Safer Gel Imaging to Translational Confidence

  2026-10-09

  Translational biology increasingly depends on preserving both molecular signal and sample integrity. This thought-leadership article uses the FMO3–TMAO aging-adipose thesis as a case study for why nucleic acid visualization should be treated as an evidence-quality decision, not merely a documentation step.

• Metformin, EDH, and Murine Colitis Microcirculation

  2026-10-09

  A 2025 European Journal of Pharmacology study identifies a direct vasorelaxant action of metformin in intestinal resistance vessels, centered on endothelium-dependent hyperpolarization and TRPV4-associated calcium signaling. Its findings suggest that preserving mucosal perfusion may contribute to metformin’s protection in experimental colitis, while remaining preliminary for human ulcerative colitis treatment.

• mRNA-Electroporated DC Therapy in Melanoma

  2026-10-08

  Wilgenhof and colleagues evaluated long-term outcomes after autologous, melanoma-antigen mRNA-electroporated dendritic-cell therapy in patients rendered disease-free by metastasis resection. The six-year follow-up supports feasibility and a clinically encouraging survival signal, but the small, single-center, nonrandomized pilot design prevents causal conclusions about treatment benefit.

• Ozone, Macrophage Efferocytosis, and Neuropathic Pain

  2026-10-08

  A 2024 Frontiers in Immunology study links ozone-associated pain relief in a mouse nerve-injury model to enhanced macrophage efferocytosis through the AMPK/Gas6-MerTK/SOCS3 pathway. Its main contribution is a mechanistic connection between apoptotic-cell clearance and reduced neuroinflammation, while its preclinical design leaves questions about pH biology, clinical translation, and long-term safety unresolved.

• Safe DNA Gel Stain: Product Overview

  2026-10-07

  Safe DNA Gel Stain (SKU A8743) is an APExBIO product described for fluorescent DNA and RNA visualization in agarose or acrylamide gels. No matched paper evidence was supplied, so performance and safety comparisons remain unverified.

• Liproxstatin-1 HCl: Ferroptosis Evidence Overview

  2026-10-07

  A source-grounded overview of Liproxstatin-1 HCl, covering ferroptosis biology, reported links between mitochondrial calcium signaling and GPX4, supplier-reported potency, conceptual research applications, evidence strength, and key limitations.

• SARS-CoV-2 N Protein and GADD34-Mediated Immunity

  2026-10-06

  Liu et al. identify a mechanism in which SARS-CoV-2 nucleocapsid protein redirects GADD34 mRNA into atypical N+/G3BP1+ foci, limiting GADD34-dependent IRF3 nuclear localization and interferon production. The study connects RNA–protein organization with innate immune antagonism while also defining important boundaries around cell-based evidence and therapeutic interpretation.

• Ademetionine and SAM-Dependent Methylation Research

  2026-10-06

  Ademetionine, also known as S-adenosylmethionine (SAM), is a central methyl-donor cofactor in biochemical research. The 2026 MaMT4 study in mulberry provides a focused example of how SAM-dependent methyltransferases can shape specialized-alkaloid biosynthesis through substrate- and position-selective methylation. Its strongest evidence comes from enzyme characterization and genetic perturbation, while transcript correlations and computational modeling remain supportive rather than definitive. The findings are relevant to conceptual work on methylation chemistry, plant metabolism, and enzyme specificity, but they do not establish clinical effects or justify extrapolation to human neurological, hepatic, or metabolic disease.

• MroGCL and Early Spermatogenesis in Giant Prawn

  2026-10-05

  Molcho et al. identified and functionally investigated MroGCL, a germ cell-less homolog associated with gonad development in the giant prawn Macrobrachium rosenbergii. Their findings link MroGCL expression and RNAi-based perturbation to spermatozoa production, while also showing that its role is partial rather than an absolute requirement for completion of spermatogenesis.

• Amiloride (MK-870): Interpreting Ion-Transport Evidence

  2026-10-05

  Amiloride (MK-870) is more than a sodium-channel research reagent: it is a pharmacological probe whose results require careful separation of target engagement, pathway effects, and disease relevance. This evidence-focused guide examines its mechanistic scope, translational applications, and the interpretive lessons from a phase 3 WHIM syndrome study.

• MDockPeP2_VS and Peptide Inhibitors of β-Lactamase

  2026-10-04

  Xu and colleagues introduced MDockPeP2_VS, a structure-based computational framework designed to make large-scale peptide screening more practical by narrowing the conformational search space. In an application to TEM-1 β-lactamase, the approach identified peptide candidates, including TF7, with reported micromolar inhibition, while also highlighting the gap between computational discovery and broader biological validation.

• TCF25, Lysosomal Acidification, and Cell Death

  2026-10-03

  A 2025 Cell Reports study identifies TCF25 as a nutrient-responsive regulator that strengthens lysosomal acidification during glucose starvation. The work links this response first to autophagy and energy maintenance, then to ferritinophagy, lysosomal membrane permeability, and lysosome-dependent cell death during prolonged stress.

7946 records 1/530 page Next 12345 下5页 Last page